Transcript Giriş - Abdi İbrahim

About the Company
To d a y ’ s A b d i I b r a h i m
Company Profile*
www.abdiibrahim.com.tr
 Shareholders:
Barut and Esirtgen Families
 Abdi Ibrahim Tower:
Istanbul, Turkey
 Production and R&D:
Esenyurt, Istanbul
 Turnover:
$853 million
 Export:
$27 million
 Production Capacity:
350 million boxes
 Product Range:
53% original pharmaceuticals
47% generic pharmaceuticals
 Licensors:
~ 30 international companies
 Employees:
~ 3,300
* As of December 2011
About the Company
Vision
To be a well-respected, widely preferred
global player that strives to grow more
rapidly than the respective pharmaceutical
market
Mission
To produce and supply healthcare products
through a pioneering and innovative
approach, for the benefit of medicine and
humanity
www.abdiibrahim.com.tr
About the Company
A Journey of 100 Years to the Summit
Istanbul
Istanbul
Algeria
 The business started in 1912 with a
small pharmacy in Istanbul
 In 1940, the number of drugs
produced at the Abdi Ibrahim
Laboratory reached 80
www.abdiibrahim.com.tr
 The foundations of the
production facilities were laid in
1994
 Portfolio: 150 brands, more than 250
products, close to 30 licensors, exports
to more than 20 countries
 In 1999, international expansion
started with the first venture into
Algeria
 EU GMP approved manufacturing
facility and first accredited R&D
Industry Leader for 9 Years
Turnover — Consolidated Turnover (Millon $)
Turnover — Consolidated Turnover (TL)
896
1,424
853
849
1,343
805
761
1,158 1,160
1,035
614
575
878
774
400
577
335
186
495
217
329
160
201
110
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
* As of December 2011
www.abdiibrahim.com.tr
Industry Leader
Domestic Sales Development
Turnover Development (TL)
Turnover Development ($ mio)
865
1,379
1,297
786
826
819
735
1,114 1,121
1,011
603
559
861
753
387
560
327
484
322
197
185
212
157
110
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Domestic sales (contract man. included)
www.abdiibrahim.com.tr
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Domestic sales turnover (contract man. included)
* As of December 2011
Industry Leader
Market Share Leader in Turkey
Market Share — Units (2011)
ABDI
9.3%
Bayer
6.8%
Bilim
6.2%
Eastpharma
5.6%
Ulugay
4.9%
Sanofi
Novartis
Market Share — $ Turnover (2011)
4.7%
3.8%
ABDI
7.9%
Novartis
6.0%
Bilim
5.1%
Pfizer
4.8%
Eastpharma
4.1%
Glaxo-SmithKline
3.8%
Sanofi
3.7%
Glaxo-SmithKline
3.4%
Bayer
3.4%
Pfizer
3.3%
Astra Zeneca
3.3%
Santa Farma
3.2%
Sanovel
www.abdiibrahim.com.tr
2.9%
Ref. IMS
Industry Leader
Export Development
31
30
27
25
19
16
13
11
8
5
3
1
2000
2001
2002
2003
2004
2005
2006
US $ million
www.abdiibrahim.com.tr
2007
2008
2009
2010
2011
Industry Leader
$274 Million Investment
(1990-2011)
48.4
Before 2000
225.2
www.abdiibrahim.com.tr
Fixed Assets
After 2000
$ million
Industry Leader
Success is a Team Game
The Largest Sales and Marketing Team in Turkey (2010 - 2011)
Number of employees
~ 3300*
2,100
550
400
150
* Includes Abdica, Reformed and International Markets
www.abdiibrahim.com.tr
Manufacturing Plant
Logistic Center
Production Capacity:
Production Area:
Employees:
Closed Area:
Total Palette Capacity:
350 million boxes
25,000 sqm
> 500
• Adhering to global standards
• cGMP and cGLP certifications
• ISO 14001 Environmental Management System
Certification
• OHSAS 18001 Work Safety Certification
• EU GMP approved facility
• “Energy-Efficient Industrial Facility” Award in
2007
• Modern, efficient and environment-friendly
technology
• 2D Matrix Codes technology in the production
line automation system
22,000 sq m
14,500
• With an investment of $35 million, Abdi
Ibrahim Logistic Center is equipped with
the latest state-of-the-art equipment
allowing for faster transport and greater
performance with fully automation system
First Accredited R&D Center
in Turkey
Total Closed Area:
Laboratory:
Pilot Production Area:
Offices:
Storage Area:
Employees:
13,600 sq m
2,000 sq m
900 sq m
450 sq m
350 sq m
> 150
High level of success in bioequivalence
studies
 CTD files for Turkey and Europe
 Accelerated development process for
equivalent products
 Development of value-added products
Global Reach
Abdi Ibrahim Global
Export to more than 20 Countries
Production of Original and Generic Pharmaceuticals
Licensing
www.abdiibrahim.com.tr
Marketing and Registration
Global
Licencors
www.abdiibrahim.com.tr
List of Countries Aİ
Operates
Own Markets
Third Party Countries
(Operation through own organization/reps)







Algeria
Kazakhstan
Azerbaijan
Georgia
Ukraine
Iraq
Moldova
(Operation through distributor)









www.abdiibrahim.com.tr
Afghanistan
Vietnam
Yemen
Albania
Libya
Hong Kong
Jordan
Russia
Turkmenistan









Kosovo
Lebanon
Germany
France
UK
Belgium
Netherlands
Canada
Uganda, Sudan,
Mauritius
List of Countries Aİ
Operates
Outlicensing Countries ( As of 2012)
•
•
•
•
•
•
•
•
•
•
•
•
www.abdiibrahim.com.tr
Brazil
Venezuella
South Africa
Tunusia
Morocco
Austria
Spain
Switzerland
Hungary
Bulgaria
Croatia
GCC
100th Year
Rational Medicine Usage Campaign
Undertaking responsibility on the “Rational Medicine Use” campaign initiated by the World Health
Organization for the first time in 1985 and applied by the T.R. Ministry of Health since 1992, Abdi
İbrahim aims to contribute to preventing the effects of irrational medicine use on the public health
and economy.
Transmitting its messages to the public with the collaboration of doctors and pharmacists via
visual and printed materials in health institutions within the context of the Rational Medicine Use
Campaign, Abdi İbrahim also aims to contribute to preventing the waste of resources and
establishment of a healthier society by reaching a broader audience via TV ads, radio spots and
magazine advertisements.
Van Gogh Alive
The Turkish pharmaceutical industry leader, Abdi İbrahim, will be celebrating its 100th anniversary
with an impressive exhibit never before experienced, in which the works of one of the most famous
artists in the world, Vincent Van Gogh, will be presented in a whole new format.
This exhibit, where the famous works of Vincent Van Gogh come to life at enormous scale,
immersing the audience in a vibrant symphony of light, color & sound reflects Abdi İbrahim’s 100
year vision, by blending art, science and technology with an innovative approach.